Spots Global Cancer Trial Database for recurrent high grade glioma
Every month we try and update this database with for recurrent high grade glioma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Hypofractionated Stereotactic Radiotherapy for Patients With Recurrent High Grade Glioma | NCT02567539 | Recurrent High ... | IMRT with or wi... Radiosensitive ... | 18 Years - | Istituto Clinico Humanitas | |
| PTCs-based Precision Treatment Strategy on Recurrent High-grade Gliomas | NCT05473923 | Recurrent High ... | Receiving chemo... | 18 Years - 75 Years | Beijing Tiantan Hospital | |
| Recurrent High Grade Glioma Treated by LITT | NCT06161610 | Recurrent High ... | LITT Control | 18 Years - | Beijing Tiantan Hospital | |
| A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Recurrent High Grade Gliomas | NCT01172964 | Adult Anaplasti... Recurrent Grade... Recurrent Grade... Adult Anaplasti... Adult Brain Tum... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Mixed Gli... Recurrent Adult... Adult Anaplasti... Recurrent High ... | flucytosine polymerase chai... immunohistochem... gene therapy pharmacological... 3-Tesla magneti... laboratory biom... therapeutic con... E. coli CD-expr... | 13 Years - | City of Hope Medical Center | |
| Hypofractionated Stereotactic Radiotherapy for Patients With Recurrent High Grade Glioma | NCT02567539 | Recurrent High ... | IMRT with or wi... Radiosensitive ... | 18 Years - | Istituto Clinico Humanitas | |
| Open-Label Study to Evaluate the Safety, Tolerability and Efficacy of the Oncolytic HSV1 MVR-C5252 | NCT06126744 | Recurrent High ... | MVR-C5252 | 18 Years - | Duke University | |
| Hypofractionated Stereotactic Radiotherapy for Patients With Recurrent High Grade Glioma | NCT02567539 | Recurrent High ... | IMRT with or wi... Radiosensitive ... | 18 Years - | Istituto Clinico Humanitas | |
| A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Recurrent High Grade Gliomas | NCT01172964 | Adult Anaplasti... Recurrent Grade... Recurrent Grade... Adult Anaplasti... Adult Brain Tum... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Mixed Gli... Recurrent Adult... Adult Anaplasti... Recurrent High ... | flucytosine polymerase chai... immunohistochem... gene therapy pharmacological... 3-Tesla magneti... laboratory biom... therapeutic con... E. coli CD-expr... | 13 Years - | City of Hope Medical Center | |
| A Phase I/IIa Study of Cerebraca Wafer Plus Adjuvant Temozolomide (TMZ) in Patients With Recurrent High Grade Glioma | NCT03234595 | Recurrent High ... | Cerebraca wafer | 20 Years - | Everfront Biotech Co., Ltd. | |
| A Phase I/IIa Study of Cerebraca Wafer Plus Adjuvant Temozolomide (TMZ) in Patients With Recurrent High Grade Glioma | NCT03234595 | Recurrent High ... | Cerebraca wafer | 20 Years - | Everfront Biotech Co., Ltd. | |
| Open-Label Study to Evaluate the Safety, Tolerability and Efficacy of the Oncolytic HSV1 MVR-C5252 | NCT06126744 | Recurrent High ... | MVR-C5252 | 18 Years - | Duke University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
